Helicobacter pylori eradication versus one-year maintenance therapy: Effect on relapse and gastritis outcome;Erradicación de Helicobacter pylori versus tratamiento de mantenimiento durante un año: Eficacia sobre la recidiva y la gastritis

Revista Espanola de Enfermedades Digestivas

Volumn 93, Issue 6, 2001, Pages 372-389

  Mones J ^a   Rodrigo, L ^a   Sancho, F ^a   Martin L ^a   Boixeda, D ^a   Artes M T ^a   Garcia Cases C ^a  

^a Pharma Consult Services   (Spain)

Author keywords

Gastritis; H. pylori eradication; Omeprazole; Ulcer relapse

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PLACEBO; RANITIDINE;

ADULT; AGED; ARTICLE; ATROPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOSCOPY; ENTERITIS; ERADICATION THERAPY; FEMALE; GASTRITIS; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTESTINE METAPLASIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REINFECTION; RELAPSE; STOMACH BIOPSY; ULCER HEALING;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS;

EID: 0034933134     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Helicobacter pylori in peptic ulcer disease
2. Current European concepts in the management of Helicobacter pylori infection
3. Ulcer and gastritis
4. Prevention of ulcer recurrence after eradication of Helicobacter pylori: A prospective long-term follow-up study
5. Helicobacter pylori recurrence after successful eradication: 5 year follow-up in the United States
6. Helicobacter pylori eradication with omeprazole, amoxycillin and clarithromycin: One week vs two weeks, and reinfection one year
7. Reappearance of Helicobacter pylori after eradication: Implications on duodenal ulcer recurrence. A prospective 6 year study
8. After the eradication of Helicobacter pylori infection, relapse is a serious problem in Turkey
9. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis
10. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study
11. Helicobacter pylori infection and atrophic gastritis. A nested case-control study in a rural town in Japan
12. Recurrence of duodenal ulcer after medical treatment
13. Audit of the outcome of peptic ulcer disease diagnosed 10 to 20 years previously
14. The omeprazole duodenal ulcer study group. Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: A double-blind, multicenter, 6-month study
15. Influence of cigarrette smoking on healing and relapse in duodenal ulcer disease
16. Bleeding peptic ulcer
17. Nonvariceal upper gastrointestinal bleeding: An update
18. Long-term management of duodenal ulcer in general practice: How best to use cimetidine?
19. Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: A light and electron microscopy study
20. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study
21. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer
22. Classification and grading of gastritis. The updated Sidney System
23. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 1
24. Treatment of duodenal ulcer with omeprazole or ranitidine in a Brazilian population: A multicenter double-blind parallel group study
25. Omeprazole
26. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment
27. Maintenance therapy for duodenal ulcer: A randomized controlled comparison of seven forms of treatment
28. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer
29. [13C] urea breath test to confirm eradication of Helicobacter pylori
30. 13C-urea breath test in Helicobacter pylori diagnosis and eradication. Correlation to histology, origin of "false" results, and influence of food intake
31. The breath test - A call for more regional use
32. Doubling the omeprazole dose (40 mg b.d. vs 20 mg b. d.) in dual therapy with amoxicillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients
33. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
34. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing
35. One week triple therapy for Helicobacter pylori: A multicentre comparative study
36. Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing
37. Cost-effectiveness analysis of different strategies for treating duodenal ulcer. Helicobacter pylori eradication versus antisecretory treatment
38. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
39. Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study
40. Unhealed duodenal ulcers despite Helicobacter pylori eradication
41. Risk factors associated with refractory peptic ulcers
42. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection
43. Peptic ulcer recurrence after Helicobacter pylori eradication: A 5-year follow-up study
44. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review
45. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy
46. Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy
47. Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients
48. Helicobacter pylori infection in a healthy population in Spain
49. Prevalence of Helicobacter pylori infection in medical professionals in Spain
50. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment
51. Evolution of histological gastritis for one year after H. pylori eradication in gastric ulcer patients
52. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis
53. Observer agreement on the grading of gastric atrophy
54. Recognizing atrophy: Another step toward a classification of gastritis
55. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: Pathogenesis and definition of gastric atrophy
56. Changes in the gastric mucosa following eradication of Helicobacter pylori
57. Long-term histologic consequences of suppression/eradication of Helicobacter pylori in antral mucosa
58. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: A prospective 1-year follow-up study